Literature DB >> 33656716

Obesity and Risk of COVID-19 Infection and Severity: Available Evidence and Mechanisms.

Behnaz Abiri1, Paul C Guest2, Mohammadreza Vafa3.   

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has resulted in worldwide research efforts to recognize people at greatest risk of developing critical illness and dying. Growing numbers of reports have connected obesity to more severe COVID-19 illness and death. Although the exact mechanism by which obesity may lead to severe COVID-19 outcomes has not yet been determined, the mechanisms appear to be multifactorial. These include mechanical changes of the airways and lung parenchyma, systemic and airway inflammation, and general metabolic dysfunction that adversely affect pulmonary function and/or response to treatment. As COVID-19 continues to spread worldwide, clinicians should carefully monitor and manage obese patients for prompt and targeted treatment.

Entities:  

Keywords:  COVID-19; Coronavirus; Metabolism; Obesity; Overweight; SARS-CoV-2

Year:  2021        PMID: 33656716     DOI: 10.1007/978-3-030-59261-5_8

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  15 in total

Review 1.  Impact of Obesity on Influenza A Virus Pathogenesis, Immune Response, and Evolution.

Authors:  Rebekah Honce; Stacey Schultz-Cherry
Journal:  Front Immunol       Date:  2019-05-10       Impact factor: 7.561

2.  Obesity and respiratory diseases.

Authors:  Christopher Zammit; Helen Liddicoat; Ian Moonsie; Himender Makker
Journal:  Int J Gen Med       Date:  2010-10-20

3.  Fasting plasma glucose is an independent predictor for severity of H1N1 pneumonia.

Authors:  Wei Wang; Hong Chen; Qiang Li; Bo Qiu; Jiajun Wang; Xiwen Sun; Ying Xiang; Jinchao Zhang
Journal:  BMC Infect Dis       Date:  2011-04-21       Impact factor: 3.090

4.  Obesity Outweighs Protection Conferred by Adjuvanted Influenza Vaccination.

Authors:  Erik A Karlsson; Tomer Hertz; Cydney Johnson; Andrew Mehle; Florian Krammer; Stacey Schultz-Cherry
Journal:  MBio       Date:  2016-08-02       Impact factor: 7.867

5.  Obesity-Related Microenvironment Promotes Emergence of Virulent Influenza Virus Strains.

Authors:  Rebekah Honce; Erik A Karlsson; Nicholas Wohlgemuth; Leonardo D Estrada; Victoria A Meliopoulos; Jiangwei Yao; Stacey Schultz-Cherry
Journal:  mBio       Date:  2020-03-03       Impact factor: 7.867

6.  Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.

Authors:  Annemarie B Docherty; Ewen M Harrison; Christopher A Green; Hayley E Hardwick; Riinu Pius; Lisa Norman; Karl A Holden; Jonathan M Read; Frank Dondelinger; Gail Carson; Laura Merson; James Lee; Daniel Plotkin; Louise Sigfrid; Sophie Halpin; Clare Jackson; Carrol Gamble; Peter W Horby; Jonathan S Nguyen-Van-Tam; Antonia Ho; Clark D Russell; Jake Dunning; Peter Jm Openshaw; J Kenneth Baillie; Malcolm G Semple
Journal:  BMJ       Date:  2020-05-22

7.  Individuals with obesity and type 2 diabetes have additional immune dysfunction compared with obese individuals who are metabolically healthy.

Authors:  Caroline Richard; Michael Wadowski; Susan Goruk; Lisa Cameron; Arya M Sharma; Catherine J Field
Journal:  BMJ Open Diabetes Res Care       Date:  2017-05-08

8.  Risk of COVID-19 for patients with obesity.

Authors:  Radwan Kassir
Journal:  Obes Rev       Date:  2020-04-13       Impact factor: 9.213

Review 9.  Back to the Future: Lessons Learned From the 1918 Influenza Pandemic.

Authors:  Kirsty R Short; Katherine Kedzierska; Carolien E van de Sandt
Journal:  Front Cell Infect Microbiol       Date:  2018-10-08       Impact factor: 5.293

View more
  2 in total

1.  IgG Antibody Response to the Pfizer BNT162b2 SARS-CoV-2 Vaccine in Healthcare Workers with Healthy Weight, Overweight, and Obesity.

Authors:  John T Bates; Andrew P Farmer; Michael A Bierdeman; Dallas R Ederer; Lauren S Carney; Denise D Montgomery; Seth T Lirette; Gailen D Marshall
Journal:  Vaccines (Basel)       Date:  2022-03-25

Review 2.  COVID-19 and the liver: What do we know so far?

Authors:  Prashant Nasa; George Alexander
Journal:  World J Hepatol       Date:  2021-05-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.